Automated description from the Alliance of Genome Resources (Release 3.0)
Predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and repressing transcription factor binding activity. Involved in cellular response to leukemia inhibitory factor. Predicted to localize to nuclear body and nucleolus. Is expressed in several structures, including brain; early embryo; and genitourinary system. Orthologous to human PRDM5 (PR/SET domain 5).